Investigating how a protein affects the processing of Alzheimer's-related molecules
The role of tetraspanin-regulated endolysosomal trafficking in Alzheimer's Disease
['FUNDING_R21'] · OKLAHOMA MEDICAL RESEARCH FOUNDATION · NIH-10806358
This study is looking at how a protein called CD151 affects the way certain molecules related to Alzheimer's disease are handled in the body, which could help us understand how the disease starts and progresses, and ultimately lead to new treatments for patients.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OKLAHOMA MEDICAL RESEARCH FOUNDATION (nih funded) |
| Locations | 1 site (OKLAHOMA CITY, UNITED STATES) |
| Trial ID | NIH-10806358 on ClinicalTrials.gov |
What this research studies
This research explores the role of a protein called CD151 in the endolysosomal trafficking of molecules related to Alzheimer's disease. By examining how CD151 influences the processing of amyloid precursor protein (APP) and its degradation, the study aims to uncover mechanisms that may contribute to the onset and progression of Alzheimer's disease. The research involves both laboratory experiments and animal models to assess the effects of CD151 removal on APP processing and related inflammation. Patients may benefit from insights gained into how Alzheimer's develops, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease, particularly those with late-onset forms.
Not a fit: Patients with early-onset Alzheimer's or those with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new approaches for preventing or treating Alzheimer's disease.
How similar studies have performed: Previous research has shown that targeting endolysosomal pathways can impact Alzheimer's pathology, suggesting this approach may yield valuable insights.
Where this research is happening
OKLAHOMA CITY, UNITED STATES
- OKLAHOMA MEDICAL RESEARCH FOUNDATION — OKLAHOMA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RICE, HEATHER C. — OKLAHOMA MEDICAL RESEARCH FOUNDATION
- Study coordinator: RICE, HEATHER C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome